The advent of insulin treatment in the early 1920s dramatically changed the prognosis for diabetes patients, particularly young, insulin-dependent diabetes, but the resultant increase in longevity was confounded by an unforeseen and immense problem—cardiovascular disorders—which constitutes a significant burden on both diabetic patients and overall medical costs. This evidence concerns the gene INS and diabetes mellitus.